US 11,787,845 B1
Synthetic plasmodium antigens, compositions, and uses thereof
John H. Adams, Tampa, FL (US); Christopher L. King, Moreland Hills, OH (US); Niraj H. Tolia, St. Louis, MO (US); Edwin Chen, St. Louis, MO (US); Nichole Diane Salinas, St. Louis, MO (US); Miriam Thankam George, Nilgris (IN); Francis B. Ntumngia, Tampa, FL (US); and Samantha Jones Barnes, Tampa, FL (US)
Assigned to UNIVERSITY OF SOUTH FLORIDA, Tampa, FL (US); WASHINGTON UNIVERSITY, St. Louis, MO (US); and CASE WESTERN RESERVE UNIVERSITY, Cleveland, OH (US)
Filed by University of South Florida, Tampa, FL (US); Washington University, St. Louis, MO (US); and Case Western Reserve University, Cleveland, OH (US)
Filed on Nov. 24, 2020, as Appl. No. 17/103,275.
Application 17/103,275 is a division of application No. 15/160,784, filed on May 20, 2016, granted, now 10,927,153.
Claims priority of provisional application 62/245,721, filed on Oct. 23, 2015.
Claims priority of provisional application 62/164,343, filed on May 20, 2015.
Int. Cl. C07K 14/445 (2006.01); A61K 39/015 (2006.01); C07K 14/00 (2006.01); A61K 39/00 (2006.01)
CPC C07K 14/445 (2013.01) [A61K 39/015 (2013.01); C07K 14/001 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/575 (2013.01)] 3 Claims
 
1. A method comprising:
administering an amount of a composition comprising a synthetic P. vivax polypeptide to a subject in need thereof one or more times, wherein the synthetic P. vivax polypeptide is SEQ ID NO: 3.